For the Inventor, By the Inventor

Enter assignee name

Tranzyme Pharma Inc.

USPTO Granted Patents = 19

CIPO Patents = 1

EPO Patents = 5

Forward Citations = 237

Loading Chart...

Loading Chart...

21 inventors (with patents filed for the assignee):

Hamid R Hoveyda (15 out of 51 patents)

Mark L Peterson (14 out of 21 patents)

Graeme Lovat Fraser (11 out of 38 patents)

4. Luc Ouellet (10 out of 13 patents)

5. Sylvie Beaubien (7 out of 9 patents)

6. Yves Dory (7 out of 10 patents)

7. Pierre Deslongchamps (7 out of 9 patents)

8. Mahesh Ramaseshan (6 out of 11 patents)

9. Éric Marsault (6 out of 10 patents)

10. Ruoxi Lan (5 out of 37 patents)

11. Kamel Benakli (5 out of 11 patents)

12. Gérald Villeneuve (4 out of 4 patents)

13. Daniel Fortin (4 out of 4 patents)

14. Eric Marsault (3 out of 24 patents)

15. Carl St-Louis (3 out of 8 patents)

19 patents: Sort by Forward Citations

1. 8557765 - Spatially-defined macrocycles incorporating peptide bond surrogates (2013-10-15),

2. 8497242 - Processes for intermediates for macrocyclic compounds (2013-07-30),

3. 8450268 - Methods of using macrocyclic modulators of the ghrelin receptor (2013-05-28),

4. 8440851 - Spatially-defined macrocyclic compounds useful for drug discovery (2013-05-14),

5. 8349887 - Methods of treating cachexia with macrocyclic modulators of the ghrelin receptor (2013-01-08),

6. 8334256 - Pharmaceutical salts of macrocyclic modulators of the ghrelin receptor (2012-12-18),

7. 8188216 - Combinatorial synthesis of libraries of macrocyclic compounds useful in drug discovery (2012-05-29),

8. 8129561 - Processes for intermediates for macrocyclic compounds (2012-03-06),

9. 8088733 - Methods of using macrocyclic agonists of the ghrelin receptor for treatment of gastrointestinal motility disorders (2012-01-03),

10. 8022252 - Spatially-defined macrocyclic compounds useful for drug discovery (2011-09-20),

11. 8008440 - Combinatorial synthesis of libraries of macrocyclic compounds useful in drug discovery (2011-08-30),

12. RE42624 - Methods of using macrocyclic modulators of the ghrelin receptor (2011-08-15),

13. RE42013 - Macrocyclic modulators of the ghrelin receptor (2010-12-27),

14. 7550431 - Spatially-defined macrocycles incorporating peptide bond surrogates (2009-06-23),

15. 7521420 - Macrocyclic antagonists of the motilin receptor (2009-04-21),

Tranzyme Pharma Inc. is a biopharmaceutical company focused on developing novel therapeutics to address diseases with significant unmet medical needs. With a mission to improve patient outcomes, Tranzyme dedicatedly works towards discovering, developing and commercializing innovative drugs. For more information about our latest advancements and ongoing projects, please visit our website.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

19 Patents

#87 in

#737 in Canada

#31,713 in the World

Tranzyme Pharma Inc.

Forward Citations = 237

21 inventors:

Hamid R Hoveyda (15 out of 51 patents)

Mark L Peterson (14 out of 21 patents)

Graeme Lovat Fraser (11 out of 38 patents)

4. Luc Ouellet (10 out of 13 patents)

5. Sylvie Beaubien (7 out of 9 patents)

Please report any incorrect information to support@idiyas.com

Loading…